Jena E Moseman

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 5

Top Topics

Electronic Health Record

Inflammatory Response

Top Venues

Journal for immunotherapy of cancer

This page only lists publications with an associated author ORCID identifier.

Publications

Donghwan Jeon, Ethan Hill, Jena E Moseman, Douglas G McNeel
Combining toll-like receptor agonists with immune checkpoint blockade affects antitumor vaccine efficacy. Journal for immunotherapy of cancer 12 (5) (2024)
Donghwan Jeon, Ethan Hill, Jena E Moseman, Douglas G McNeel
Combining toll-like receptor agonists with immune checkpoint blockade affects antitumor vaccine efficacy. Journal for immunotherapy of cancer 12 (5) (2024)
Donghwan Jeon, Ethan Hill, Jena E Moseman, Douglas G McNeel
Combining toll-like receptor agonists with immune checkpoint blockade affects antitumor vaccine efficacy. Journal for immunotherapy of cancer 12 (5) (2024)
Donghwan Jeon, Ethan Hill, Jena E Moseman, Douglas G McNeel
Combining toll-like receptor agonists with immune checkpoint blockade affects antitumor vaccine efficacy. Journal for immunotherapy of cancer 12 (5) (2024)
Prashant Trikha, Jena E Moseman, Aarohi Thakkar, Amanda R Campbell, Ezgi Elmas, Jennifer A Foltz, Nitin Chakravarti, James R Fitch, Elaine R Mardis, Amanda J Lee
Defining the AHR-regulated transcriptome in NK cells reveals gene expression programs relevant to development and function. Blood advances 5 (22) (2021)